Crawford Investment Counsel’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
ICM
Crawford Investment Counsel's CNMD Position: Q2 2026 in Review
Crawford Investment Counsel reduced its CONMED (CNMD) stake by 6% in Q2 2026, selling an estimated $18K and leaving 7,808 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #294.
Crawford Investment Counsel first reported a position in CNMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $18.6M in Q2 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Crawford Investment Counsel held 7,808 shares of CONMED worth $256K as of Q2 2026.
- Crawford Investment Counsel sold 500 CONMED shares in Q2 2026, an estimated $18K.
- CONMED made up ﹤0.01% of Crawford Investment Counsel's portfolio in Q2 2026, its #294 holding.
- Crawford Investment Counsel first reported a position in CONMED in Q1 2020 and has held it in 26 quarters since.
- Crawford Investment Counsel's CONMED position peaked at $18.6M in Q2 2023.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Crawford Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.